NATCO Pharma Limited Share Price and Company Fundamentals



Price
₹574.65
Change
-6.300 (-1.084%)
52 week
545.0 - 944.0

Last traded: Today at 10:00 AM

NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF; and agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. The company markets its products in approximately 50 countries. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

Key Metrics

PE ratio

26.10

PB ratio

2.32

Dividend yield

1.08%

Beta

0.48

Market cap

-

Enterprise value

-

Company profile

Industry / Sector Drug Manufacturers—Specialty & Generic / Healthcare
Full time employees 4025
Website https://www.natcopharma.co.in
Mailing address NATCO House Road No. 2 Banjara Hills Hyderabad 500034 India
Phone / Fax 91 40 2354 7532 / 91 40 2354 8243

Dividends

Dividend yield

1.08%

Dividend amount

₹6.25

Payout ratio

26.91%

5Y Avg. yield

0.91%

NATCO Pharma Limited paid ₹6.25 dividend and the ex-dividend date was 21 Nov 2022.The dividend payout ratio is 26.91%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.NATCOPHARM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

NATCOPHARM's forward dividend amount is ₹6.75 and the forward dividend yield is 1.16%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Dec 2022, following are the company executives and directors listed on NATCO Pharma Limited.

Name Title Age Total Pay
Mr. Rajeev Nannapaneni CEO & Director 44
Mr. S. V. V. N. Appa Rao Chief Financial Officer
Dr. Donthineni Linga Rao M.D. Pres of Technical Affairs & Whole Time Director 69
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. MD & Director 76
Mr. Potluri Sivaramakrishna Prasad Exec. VP of Corp. Engineering Services & Whole Time Director 63
Sanivarapu Raviprakash Reddy Sr. VP of Operations
Mr. Chekuri Venkat Ramesh C.S. Company Sec. & Compliance Officer
Ravi Kiran Namburi VP of Marketing & Sales -Domestic
Mr. A. Lakshminarayana VP of HR & Organisational Devel. 58
Dr. Bhimavarapu Rami Reddy Director of FDF 68

Profitability and management effectiveness

Profit margin

16.45%

Operating margin

18.20%

Return on assets

5.56%

Return on equity

9.25%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of NATCO Pharma Limited is and its enterprise value is .

The NATCOPHARM's stocks Beta value is 0.48 making it 52% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

NATCO Pharma Limited (NSE:NATCOPHARM) Frequently Asked Questions

1. What is NATCO Pharma Limited's Stock Symbol?

NATCO Pharma Limited trades on NSE under the ticker symbol "NATCOPHARM".

2. What is NATCO Pharma Limited's stock price today?

One share of NATCOPHARM stock can currently be purchased for approximately ₹574.65.

3. How can I contact NATCO Pharma Limited?

NATCO Pharma Limited's mailing address is NATCO House Road No. 2 Banjara Hills Hyderabad 500034 India. The company can be reached via phone at 91 40 2354 7532.

4. What is NATCO Pharma Limited's official website?

The official website of NATCO Pharma Limited is https://www.natcopharma.co.in.